Valley Wealth Managers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$764K Sell
3,125
-23,789
-88% -$5.54M 0.05% 143
2025
Q4
$5.57M Sell
26,914
-416
-2% -$82.3K 0.36% 59
2025
Q3
$5.07M Buy
27,330
+1,135
+4% +$194K 0.34% 62
2025
Q2
$4M Buy
26,195
+1,015
+4% +$156K 0.29% 84
2025
Q1
$4.18M Buy
25,180
+1,510
+6% +$236K 0.32% 69
2024
Q4
$3.42M Buy
23,670
+763
+3% +$118K 0.26% 85
2024
Q3
$3.71M Sell
22,907
-79
-0.3% -$12.6K 0.28% 90
2024
Q2
$3.36M Sell
22,986
-695
-3% -$103K 0.27% 93
2024
Q1
$3.75M Sell
23,681
-95,630
-80% -$15.2M 0.28% 91
2023
Q4
$18.7M Buy
119,311
+2,170
+2% +$333K 1.46% 27
2023
Q3
$18.2M Sell
117,141
-3,121
-3% -$515K 1.52% 21
2023
Q2
$19.9M Sell
120,262
-2,463
-2% -$398K 1.79% 14
2023
Q1
$19M Buy
122,725
+1,183
+1% +$191K 1.73% 19
2022
Q4
$21.5M Sell
121,542
-2,878
-2% -$497K 1.99% 11
2022
Q3
$20.3M Buy
124,420
+552
+0.4% +$93.4K 2.03% 9
2022
Q2
$22M Sell
123,868
-5,721
-4% -$1.02M 2.06% 10
2022
Q1
$23M Buy
129,589
+3,299
+3% +$561K 1.92% 13
2021
Q4
$21.6M Buy
126,290
+556
+0.4% +$91K 1.73% 16
2021
Q3
$20.3M Sell
125,734
-252
-0.2% -$43K 1.77% 15
2021
Q2
$20.8M Buy
125,986
+2,936
+2% +$486K 1.76% 17
2021
Q1
$20.2M Buy
123,050
+1,326
+1% +$215K 1.82% 20
2020
Q4
$19.2M Buy
121,724
+1,092
+0.9% +$161K 1.87% 17
2020
Q3
$18M Buy
120,632
+1,422
+1% +$210K 1.98% 16
2020
Q2
$16.8M Sell
119,210
-995
-0.8% -$145K 1.88% 17
2020
Q1
$15.8M Sell
120,205
-351
-0.3% -$49.8K 2.05% 14
2019
Q4
$17.6M Sell
120,556
-2,245
-2% -$305K 1.76% 28
2019
Q3
$15.9M Sell
122,801
-37,213
-23% -$4.9M 1.69% 31
2019
Q2
$22.3M Buy
160,014
+3,605
+2% +$499K 2.37% 3
2019
Q1
$21.9M Buy
156,409
+169
+0.1% +$22.6K 2.38% 3
2018
Q4
$20.2M Buy
156,240
+8,455
+6% +$1.18M 2.63% 3
2018
Q3
$20.4M Sell
147,785
-1,375
-0.9% -$183K 2.41% 7
2018
Q2
$18.1M Buy
149,160
+504
+0.3% +$62.9K 2.21% 16
2018
Q1
$19.1M Buy
148,656
+5,037
+4% +$681K 2.32% 6
2017
Q4
$20.1M Sell
143,619
-1,857
-1% -$259K 2.41% 5
2017
Q3
$18.9M Sell
145,476
-1,959
-1% -$260K 2.38% 4
2017
Q2
$19.5M Sell
147,435
-2,807
-2% -$358K 2.61% 3
2017
Q1
$18.7M Buy
150,242
+2,627
+2% +$314K 2.48% 4
2016
Q4
$17M Buy
147,615
+1,598
+1% +$185K 2.43% 4
2016
Q3
$17.2M Buy
146,017
+2,755
+2% +$334K 2.54% 4
2016
Q2
$17.4M Buy
143,262
+4,528
+3% +$515K 2.65% 2
2016
Q1
$15M Sell
138,734
-1,986
-1% -$206K 2.54% 3
2015
Q4
$14.5M Sell
140,720
-3,896
-3% -$392K 2.59% 3
2015
Q3
$13.5M Buy
144,616
+6,573
+5% +$636K 2.46% 6
2015
Q2
$13.5M Buy
138,043
+4,843
+4% +$485K 2.34% 12
2015
Q1
$13.4M Buy
133,200
+3,306
+3% +$336K 2.31% 10
2014
Q4
$13.6M Buy
129,894
+3,411
+3% +$359K 2.43% 9
2014
Q3
$13.5M Sell
126,483
-156
-0.1% -$16.2K 2.58% 2
2014
Q2
$13.2M Sell
126,639
-828
-0.6% -$83.7K 2.52% 5
2014
Q1
$12.5M Sell
127,467
-335
-0.3% -$31.1K 2.5% 5
2013
Q4
$11.7M Sell
127,802
-3,538
-3% -$326K 2.4% 10
2013
Q3
$11.4M Sell
131,340
-1,215
-0.9% -$109K 2.49% 6
2013
Q2
$11.4M Buy
+132,555
New +$11.2M 2.58% 4

Other funds holding JNJ

Valley Wealth Managers's JNJ Position: Q1 2026 in Review

Valley Wealth Managers reduced its Johnson & Johnson (JNJ) stake by 88% in Q1 2026, selling an estimated $5.54M and leaving 3,125 shares worth $764K. The position accounts for 0.05% of the portfolio, ranked #143.

Valley Wealth Managers first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $23M in Q1 2022. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Valley Wealth Managers held 3,125 shares of Johnson & Johnson worth $764K as of Q1 2026.
  • Valley Wealth Managers sold 23,789 Johnson & Johnson shares in Q1 2026, an estimated $5.54M.
  • Johnson & Johnson made up 0.05% of Valley Wealth Managers's portfolio in Q1 2026, its #143 holding.
  • Valley Wealth Managers first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Valley Wealth Managers's Johnson & Johnson position peaked at $23M in Q1 2022.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Valley Wealth Managers's 13F filing for Q1 2026, filed 6 May 2026.